COCAINE-INDUCED BEHAVIOR - DOPAMINE-D1 RECEPTOR ANTAGONISM BY SCH-23390 PREVENTS EXPRESSION OF CONDITIONED SENSITIZATION FOLLOWING REPEATED ADMINISTRATION OF COCAINE

被引:55
作者
MCCREARY, AC [1 ]
MARSDEN, CA [1 ]
机构
[1] QUEENS MED CTR,SCH MED,DEPT PHYSIOL & PHARMACOL,NOTTINGHAM NG7 2UH,ENGLAND
关键词
COCAINE; D1; RECEPTOR; D2; SCH-23390; HALOPERIDOL; COCAINE-INDUCED BEHAVIOR;
D O I
10.1016/0028-3908(93)90161-U
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Repeated administration of cocaine (15 mg/kg) (once a week for 4 weeks, day 1, 7, 14 and 21) in a conditioned environment produced significant hyperactivity and head bobbing effects which showed sensitisation. Pretreatment with the D1 antagonist SCH 23390 (0.05 mg/kg), a dose that blocked d-amphetamine (2.5 mg/kg)-induced hyperactivity, antagonised the locomotor effects of cocaine after the second (day 7), third (day 14) and fourth (day 21) administration of cocaine but not the first day (day 1). Antagonism of head bobbing occurred on all 4 (1, 7, 14 and 21) days of treatment. In contrast, haloperidol (0.1 mg/kg ) significantly reduced amphetamine-induced hyperactivity but potentiated the locomotor and stereotypic effects of cocaine, after administration of cocaine on days 1 and 7 and had no effect on cocaine-induced behaviour on days 14 and 21. The results suggest that the locomotor effects and head bobbing produced by cocaine, together with the expression of sensitisation to these effects in the conditioned environment, involve activation of post-synaptic D1 receptors. The potentiation of the effects of cocaine by a small dose of haloperidol may indicate increased release of dopamine due to blockade of pre-synaptic D2 autoreceptors.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 27 条
[1]  
Angrist B., 1983, STIMULANTS NEUROCHEM, P1
[2]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[3]   CHRONIC COCAINE ENHANCES SEROTONIN AUTOREGULATION AND SEROTONIN UPTAKE BINDING [J].
CUNNINGHAM, KA ;
PARIS, JM ;
GOEDERS, NE .
SYNAPSE, 1992, 11 (02) :112-123
[4]  
DAWSON GR, 1990, BRIT J PHARMACOL, V101, pP587
[5]  
DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274
[6]  
DICHIARA G, 1985, J PHARMACOL EXP THER, V235, P487
[7]  
Downs AW, 1932, J PHARMACOL EXP THER, V46, P199
[8]  
GOEDERS NE, 1987, ALCOHOL DRUG RES, V7, P207
[9]   SELF-INHIBITION BY DOPAMINERGIC-NEURONS [J].
GROVES, PM ;
WILSON, CJ ;
YOUNG, SJ ;
REBEC, GV .
SCIENCE, 1975, 190 (4214) :522-529
[10]  
HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833